These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25670512)

  • 41. Annotating single amino acid polymorphisms in the UniProt/Swiss-Prot knowledgebase.
    Yip YL; Famiglietti M; Gos A; Duek PD; David FP; Gateau A; Bairoch A
    Hum Mutat; 2008 Mar; 29(3):361-6. PubMed ID: 18175334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
    Klein TE; Altman RB
    Pharmacogenomics J; 2004; 4(1):1. PubMed ID: 14735107
    [No Abstract]   [Full Text] [Related]  

  • 43. An XML-based interchange format for genotype-phenotype data.
    Whirl-Carrillo M; Woon M; Thorn CF; Klein TE; Altman RB
    Hum Mutat; 2008 Feb; 29(2):212-9. PubMed ID: 17994540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Report calls for better evaluation of pharmacogenetic tests.
    Moynihan R
    BMJ; 2003 Jul; 327(7405):11. PubMed ID: 12842941
    [No Abstract]   [Full Text] [Related]  

  • 45. Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases.
    Piana C; Surh L; Furst-Recktenwald S; Iolascon A; Jacqz-Aigrain EM; Jonker I; Russo R; van Schaik RH; Wessels J; Della Pasqua OE
    J Clin Pharmacol; 2012 May; 52(5):704-16. PubMed ID: 21566202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacogenetic testing: time for clinical practice guidelines.
    Amstutz U; Carleton BC
    Clin Pharmacol Ther; 2011 Jun; 89(6):924-7. PubMed ID: 21508939
    [No Abstract]   [Full Text] [Related]  

  • 47. Meaningful use of pharmacogenomics in health records: semantics should be made explicit.
    Shabo Shvo A
    Pharmacogenomics; 2010 Jan; 11(1):81-7. PubMed ID: 20017674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PharmGKB Drug Data Normalization with NDF-RT.
    Zhu Q; Freimuth RR; Pathak J; Chute CG
    AMIA Jt Summits Transl Sci Proc; 2013; 2013():180. PubMed ID: 24303334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue-Specific Analysis of Pharmacological Pathways.
    Hao Y; Quinnies K; Realubit R; Karan C; Tatonetti NP
    CPT Pharmacometrics Syst Pharmacol; 2018 Jul; 7(7):453-463. PubMed ID: 29920991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CATCH-KB: Establishing a Pharmacogenomics Variant Repository for Chemotherapy-Induced Cardiotoxicity.
    Morash M; Mitchell H; Yu A; Campion T; Beltran H; Elemento O; Pathak J
    AMIA Jt Summits Transl Sci Proc; 2018; 2017():168-177. PubMed ID: 29888066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple testing in big data.
    Knottnerus JA; Tugwell P
    J Clin Epidemiol; 2014 Aug; 67(8):843-4. PubMed ID: 24947125
    [No Abstract]   [Full Text] [Related]  

  • 52. Future-Proofing Your
    Baltrus DA; Cuomo CA; Dennehy JJ; Dunning Hotopp JC; Maresca JA; Newton ILG; Rasko DA; Rokas A; Roux S; Stajich JE
    Microbiol Resour Announc; 2019 Sep; 8(36):. PubMed ID: 31488541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meaningful use and clinical utility of preemptive pharmacogenetic testing: (re)view from a CYP2D6 poor metabolizer.
    Leeder JS
    Clin Pharmacol Ther; 2015 Feb; 97(2):119-21. PubMed ID: 25670513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas.
    Dorfman EH; Brown Trinidad S; Morales CT; Howlett K; Burke W; Woodahl EL
    Pharmacogenomics; 2015; 16(3):227-37. PubMed ID: 25712186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline.
    Chaplin M; Kirkham JJ; Dwan K; Sloan DJ; Davies G; Jorgensen AL
    PLoS Med; 2020 Sep; 17(9):e1003344. PubMed ID: 32956352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Essential Characteristics of Pharmacogenomics Study Publications.
    Thorn CF; Whirl-Carrillo M; Hachad H; Johnson JA; McDonagh EM; Ratain MJ; Relling MV; Scott SA; Altman RB; Klein TE
    Clin Pharmacol Ther; 2019 Jan; 105(1):86-91. PubMed ID: 30406943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Big Data Transforms Discovery-Utilization Therapeutics Continuum.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2016 Mar; 99(3):250-4. PubMed ID: 26888297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Database: A New Article Type in CPT: Pharmacometrics & Systems Pharmacology.
    Li L; van der Graaf PH
    CPT Pharmacometrics Syst Pharmacol; 2015 Aug; 4(8):443-4. PubMed ID: 26380152
    [No Abstract]   [Full Text] [Related]  

  • 59. Enabling the curation of your pharmacogenetic study.
    McDonagh Em; Whirl-Carrillo M; Altman RB; Klein TE
    Clin Pharmacol Ther; 2015 Feb; 97(2):116-9. PubMed ID: 25670512
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.